Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19. (19th July 2020) - Wilson, Andrew J.; Troy‐Barnes, Ethan; Subhan, Maryam; Clark, Fiona; Gupta, Rajeev; Fielding, Adele K.; Kottaridis, Panagiotis; Mansour, Marc R.; O'Nions, Jenny; Payne, Elspeth; Chavda, Naina; Baker, Robert; et al.